Human papillomavirus infection in “young” versus “old” patients with squamous cell carcinoma of the head and neck
✍ Scribed by Elizabeth A. Sisk; Carol R. Bradford; Abraham Jacob; Christopher H. Yian; Kim M. Staton; Gong Tang; Monte O. Harris; Thomas E. Carey; Wayne D. Lancaster; Lucie Gregoire
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 262 KB
- Volume
- 22
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Gm, A2m, and Km allotypic markers were examined in 40 Caucasian patients with squamous cell carcinomas of the head and neck. Serum IgA levels, the A2m(l) allotypic marker, and antibodies against IgAl, A2m(l), and A2m(2) were measured quantitatively. The frequency of Km(1) was found to be significant
Background. Comorbid conditions have a significant impact on the actuarial survival of patients with head and neck cancer. However, no studies have evaluated the impact of comorbidity on tumor-and treatment-specific outcomes. This study was performed to evaluate the impact of comorbidity, graded by
Human papillomaviruses (HPVs) have been recognized as an essential pathogenic factor in anogenital cancer. HPV DNA has also been found in a subgroup of head-and-neck squamous-cell carcinomas (HNSCCs), and a causative role of the virus in the development of these tumors has been suggested by the conc